{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:03:14Z","timestamp":1778634194512,"version":"3.51.4"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007637","name":"Departamento Administrativo de Ciencia Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008648","name":"Pfizer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.thromres.2021.02.025","type":"journal-article","created":{"date-parts":[[2021,2,27]],"date-time":"2021-02-27T08:12:58Z","timestamp":1614413578000},"page":"73-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Coagulation disorders in Chagas disease: A pathophysiological systematic review and meta-analysis"],"prefix":"10.1016","volume":"201","author":[{"given":"Luis E.","family":"Echeverr\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyda Z.","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Alejandro","family":"G\u00f3mez-Ochoa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2021.02.025_bb0005","author":"Lidani"},{"key":"10.1016\/j.thromres.2021.02.025_bb0010","author":"Bartsch"},{"key":"10.1016\/j.thromres.2021.02.025_bb0015","author":"Tarleton"},{"issue":"10115","key":"10.1016\/j.thromres.2021.02.025_bb0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet Lond Engl."},{"issue":"11","key":"10.1016\/j.thromres.2021.02.025_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.117.004361","article-title":"Contemporary characteristics and outcomes in chagasic heart failure compared with other nonischemic and ischemic cardiomyopathy","volume":"10","author":"Shen","year":"2017","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.thromres.2021.02.025_bb0030","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.gheart.2015.07.006","article-title":"Prevalence and risk factors of embolic cerebrovascular events associated with Chagas heart disease","volume":"10","author":"Nunes","year":"2015","journal-title":"Glob Heart. septiembre de"},{"issue":"6","key":"10.1016\/j.thromres.2021.02.025_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006567","article-title":"Electrocardiographic abnormalities in Chagas disease in the general population: a systematic review and meta-analysis","volume":"12","author":"Rojas","year":"2018","journal-title":"PLoS Negl Trop Dis."},{"issue":"12","key":"10.1016\/j.thromres.2021.02.025_bb0040","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cardfail.2014.09.003","article-title":"Chagas cardiomyopathy is associated with higher incidence of stroke: a meta-analysis of observational studies","volume":"20","author":"Cardoso","year":"2014","journal-title":"J Card Fail."},{"issue":"5","key":"10.1016\/j.thromres.2021.02.025_bb0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1474-4422(10)70042-9","article-title":"Chagas disease and stroke","volume":"9","author":"Carod-Artal","year":"2010","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.thromres.2021.02.025_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004269","article-title":"Altered hypercoagulability factors in patients with chronic chagas disease: potential biomarkers of therapeutic response","volume":"10","author":"Pinazo","year":"2016","journal-title":"PLoS Negl Trop Dis."},{"issue":"1","key":"10.1016\/j.thromres.2021.02.025_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.11613\/BM.2012.006","article-title":"Inflammation and haemostasis","volume":"22","author":"Margetic","year":"2012","journal-title":"Biochem Medica"},{"issue":"7","key":"10.1016\/j.thromres.2021.02.025_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2016.39","article-title":"Platelets and coagulation in infection","volume":"5","author":"Davis","year":"2016","journal-title":"Clin Transl Immunol."},{"issue":"7","key":"10.1016\/j.thromres.2021.02.025_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLOS Med."},{"issue":"1","key":"10.1016\/j.thromres.2021.02.025_bb0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10654-019-00576-5","article-title":"A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research","volume":"35","author":"Muka","year":"2020","journal-title":"Eur J Epidemiol."},{"issue":"1","key":"10.1016\/j.thromres.2021.02.025_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol."},{"key":"10.1016\/j.thromres.2021.02.025_bb0080","doi-asserted-by":"crossref","DOI":"10.1590\/1518-8345.2885.3074","article-title":"The Joanna Briggs Institute approach for systematic reviews","volume":"26","author":"Santos","year":"2018","journal-title":"Rev Lat Am Enfermagem"},{"issue":"6","key":"10.1016\/j.thromres.2021.02.025_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218260","article-title":"Impaired frequencies and function of platelets and tissue remodeling in chronic Chagas disease","volume":"14","author":"Pengue","year":"2019","journal-title":"PLOS ONE"},{"issue":"5","key":"10.1016\/j.thromres.2021.02.025_bb0090","first-page":"502","article-title":"Inflammatory and prothrombotic activation with conserved endothelial function in patients with chronic, asymptomatic Chagas disease","volume":"17","author":"Herrera","year":"2011","journal-title":"Clin Appl Thromb Off J Int Acad Clin Appl Thromb."},{"key":"10.1016\/j.thromres.2021.02.025_bb0095","first-page":"38","article-title":"Estado protromb\u00f3tico en estadios tempranos de la enfermedad de Chagas cr\u00f3nica: Su asociaci\u00f3n con factores de riesgo tromb\u00f3tico","volume":"75","author":"Herrera","year":"2005","journal-title":"Arch Cardiol M\u00e9xico"},{"key":"10.1016\/j.thromres.2021.02.025_bb0100","author":"dos Santos"},{"issue":"5","key":"10.1016\/j.thromres.2021.02.025_bb0105","first-page":"655","article-title":"Study of prothrombotic and proinflammatory factors in chagas cardiomyopathy","volume":"95","author":"de Melo","year":"2010","journal-title":"Arq Bras Cardiol."},{"issue":"3","key":"10.1016\/j.thromres.2021.02.025_bb0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2249.1999.01070.x","article-title":"Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas\u2019 disease","volume":"118","author":"Laucella","year":"1999","journal-title":"Clin Exp Immunol."},{"issue":"4","key":"10.1016\/j.thromres.2021.02.025_bb0115","first-page":"617","article-title":"Hypercoagulability biomarkers in Trypanosoma cruzi -infected patients","volume":"106","author":"Pinazo","year":"2011","journal-title":"Thromb Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2021.02.025_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1617-9625-1-3","article-title":"The influence of tobacco smoking on adhesion molecule profiles","volume":"1","author":"Scott","year":"2002","journal-title":"Tob Induc Dis."},{"issue":"3","key":"10.1016\/j.thromres.2021.02.025_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/00365513.2017.1292363","article-title":"P-selectin, endocan, and some adhesion molecules in obese children and adolescents with non-alcoholic fatty liver disease","volume":"77","author":"Ustyol","year":"2017","journal-title":"Scand J Clin Lab Invest. mayo de"},{"issue":"17","key":"10.1016\/j.thromres.2021.02.025_bb0130","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1182\/blood-2013-09-526277","article-title":"Multiple roles of the coagulation protease cascade during virus infection","volume":"123","author":"Antoniak","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2021.02.025_bb0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1590\/S0037-86821991000200006","article-title":"Association of encephalic vascular accidents and Chagas disease","volume":"24","author":"Lopes","year":"1991","journal-title":"Rev Soc Bras Med Trop"},{"issue":"2","key":"10.1016\/j.thromres.2021.02.025_bb0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1590\/S0004-282X1984000200002","article-title":"Ischemic cerebral changes in the chronic chagasic cardiopathy","volume":"42","author":"Pitella","year":"1984","journal-title":"Arq Neuropsiquiatr."},{"issue":"4","key":"10.1016\/j.thromres.2021.02.025_bb0145","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1590\/S0066-782X2003001200008","article-title":"Cerebral infarction in autopsies of chagasic patients with heart failure","volume":"81","author":"Aras","year":"2003","journal-title":"Arq Bras Cardiol."},{"issue":"5","key":"10.1016\/j.thromres.2021.02.025_bb0150","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1161\/01.STR.0000163104.92943.50","article-title":"Chagasic cardiomyopathy is independently associated with ischemic stroke in chagas disease","volume":"36","author":"Javier","year":"2005","journal-title":"Stroke"},{"issue":"1\u20132","key":"10.1016\/j.thromres.2021.02.025_bb0155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jns.2008.12.015","article-title":"Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study","volume":"278","author":"Nunes","year":"2009","journal-title":"J Neurol Sci."},{"issue":"1","key":"10.1016\/j.thromres.2021.02.025_bb0160","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2143\/AC.55.1.2005715","article-title":"Stroke in a hospital-derived cohort of patients with chronic Chagas\u2019 disease","volume":"55","author":"Bestetti","year":"2000","journal-title":"Acta Cardiol. febrero de"},{"key":"10.1016\/j.thromres.2021.02.025_bb0165","doi-asserted-by":"crossref","unstructured":"Nunes MCP, Beaton A, Acquatella H, Bern C, Bolger AF, Echeverr\u00eda LE, et al. Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation. 18 de 2018;138(12):e169\u2013209.","DOI":"10.1161\/CIR.0000000000000599"},{"issue":"4","key":"10.1016\/j.thromres.2021.02.025_bb0170","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/oxfordjournals.bmb.a072930","article-title":"Mechanisms, markers and management of coagulation activation","volume":"50","author":"Mannucci","year":"1994","journal-title":"Br Med Bull."},{"issue":"2","key":"10.1016\/j.thromres.2021.02.025_bb0175","first-page":"88","article-title":"Endogenous thrombin potential in practical use","volume":"31","author":"Wilkens","year":"2011","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.thromres.2021.02.025_bb0180","series-title":"Mediators of Inflammation","first-page":"e798078","article-title":"Tumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas\u2019 heart disease","volume":"Vol. 2014","author":"Pereira","year":"2014"},{"issue":"1","key":"10.1016\/j.thromres.2021.02.025_bb0185","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1157\/13083649","article-title":"C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure","volume":"59","author":"L\u00f3pez","year":"2006","journal-title":"Rev Esp Cardiol."},{"issue":"12","key":"10.1016\/j.thromres.2021.02.025_bb0190","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.ATV.0000095974.95122.EC","article-title":"Platelets in inflammation and thrombosis","volume":"23","author":"Wagner","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"6","key":"10.1016\/j.thromres.2021.02.025_bb0195","first-page":"242","article-title":"Platelet-vessel wall interaction in health and disease","volume":"68","author":"L\u00f6wenberg","year":"2010","journal-title":"Neth J Med"},{"issue":"12","key":"10.1016\/j.thromres.2021.02.025_bb0200","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J Clin Invest."},{"issue":"4","key":"10.1016\/j.thromres.2021.02.025_bb0205","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1055\/s-0037-1615646","article-title":"Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation","volume":"85","author":"Berckmans","year":"2001","journal-title":"Thromb Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2021.02.025_bb0210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0021-9150(99)00241-5","article-title":"Platelets induce alterations of chemotactic and adhesive properties of endothelial cells mediated through an interleukin-1-dependent mechanism. Implications for atherogenesis","volume":"148","author":"Gawaz","year":"2000","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.thromres.2021.02.025_bb0215","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/ATVBAHA.107.140046","article-title":"Vascular functions of the plasminogen activation system","volume":"27","author":"Fay","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"6","key":"10.1016\/j.thromres.2021.02.025_bb0220","first-page":"969","article-title":"Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins","volume":"100","author":"Kruithof","year":"2008","journal-title":"Thromb Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2021.02.025_bb0225","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator INHIBITOR-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari","year":"2010","journal-title":"Cardiovasc Ther."},{"issue":"3","key":"10.1016\/j.thromres.2021.02.025_bb0230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1590\/S0074-02762003000300021","article-title":"Increased plasma levels of tumor necrosis factor-alpha in asymptomatic\/\u201cindeterminate\u201d and Chagas disease cardiomyopathy patients","volume":"98","author":"Ferreira","year":"2003","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"10.1016\/j.thromres.2021.02.025_bb0235","doi-asserted-by":"crossref","unstructured":"Pissetti CW, Correia D, de Oliveira RF, Llaguno MM, Balarin MAS, Silva-Grecco RL, et al. Genetic and functional role of TNF-alpha in the development Trypanosoma cruzi infection. PLoS Negl Trop Dis [Internet]. 8 de marzo de 2011 [citado 17 de agosto de 2020];5(3). Disponible en: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3050938\/.","DOI":"10.1371\/journal.pntd.0000976"},{"issue":"2","key":"10.1016\/j.thromres.2021.02.025_bb0240","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0020-7519(01)00322-8","article-title":"Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi","volume":"32","author":"Gao","year":"2002","journal-title":"Int J Parasitol."},{"issue":"2","key":"10.1016\/j.thromres.2021.02.025_bb0245","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood-2017-02-770479","article-title":"Circulating soluble P-selectin must dimerize to promote inflammation and coagulation in mice","volume":"130","author":"Panicker","year":"2017","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2021.02.025_bb0250","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1538-7836.2005.01373.x","article-title":"The P-selectin, tissue factor, coagulation triad","volume":"3","author":"Polgar","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2021.02.025_bb0255","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1471-4914(03)00071-6","article-title":"The role of selectins in inflammation and disease","volume":"9","author":"Ley","year":"2003","journal-title":"Trends Mol Med."},{"issue":"3","key":"10.1016\/j.thromres.2021.02.025_bb0260","first-page":"746","article-title":"Adhesive interactions of leukocytes, platelets, and the vessel wall during hemostasis and inflammation","volume":"86","author":"McEver","year":"2001","journal-title":"Thromb Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2021.02.025_bb0265","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1365-2141.1993.tb03149.x","article-title":"Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome","volume":"84","author":"Katayama","year":"1993","journal-title":"Br J Haematol."},{"issue":"6","key":"10.1016\/j.thromres.2021.02.025_bb0270","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1182\/blood.V83.6.1535.1535","article-title":"Plasma P-selectin is increased in thrombotic consumptive platelet disorders","volume":"83","author":"Chong","year":"1994","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2021.02.025_bb0275","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1515\/CCLM.2004.082","article-title":"The emerging value of P-selectin as a disease marker","volume":"42","author":"Kappelmayer","year":"2004","journal-title":"Clin Chem Lab Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821000803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821000803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:45:07Z","timestamp":1758735907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384821000803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":55,"alternative-id":["S0049384821000803"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.02.025","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coagulation disorders in Chagas disease: A pathophysiological systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.02.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}